Vimseltinib (DCC-3014) MOTION

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Francis Riedel Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Deciphera Pharmaceuticals, LLC

Start Date

March 16, 2022

End Date

May 31, 2026

Administered By

Duke Cancer Institute

Awarded By

Deciphera Pharmaceuticals, LLC

Start Date

March 16, 2022

End Date

May 31, 2026